Featured news from NHIVNA

HIV-related news from NAM

High-dose rifampicin for TB treatment regimen may improve survival in people with low CD4 cell counts
Theo Smart, 2016-07-26 16:20:00

More aggressive TB treatment using high dose of rifampicin, in addition to ARV treatment, could reduce TB/HIV mortality among co-infected TB/HIV patients with a severe immunocompromised state, according to Corinne Merle of the London School of Hygiene & Tropical Medicine who presented the results of the three-arm RAFA trial last week at the 21st International AIDS Conference (AIDS 2016) in Durban, South Africa.